Treatment of CD30-Negative Refractory Mycosis Fungoides With Brentuximab Vedotin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of CD30-Negative Refractory Mycosis Fungoides With Brentuximab Vedotin

Published:2018-01-01 Issue:1 Volume:154 Page:109
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Zhang Connie¹,Chairatchaneeboon Manasmon²,Haun Paul³,Landsburg Daniel⁴,Kim Ellen J.³

Affiliation:

1. Division of Dermatology, University of Calgary, Calgary, Alberta, Canada

2. Department of Dermatology, Mahidol University, Bangkok, Thailand

3. Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia

4. Division of Hematology-Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia

Publisher

American Medical Association (AMA)

Subject

Dermatology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023;European Journal of Cancer;2023-12

2. CD30 in Cutaneous Pathology;The American Journal of Dermatopathology;2023-09

3. Integrating novel agents into the treatment of advanced mycosis fungoides and Sézary syndrome;Blood;2023-02-16

4. Brentuximab vedotin in the treatment of cutaneous T‐cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry;Journal of the European Academy of Dermatology and Venereology;2022-09-09

5. CD30+ Lymphoproliferative Disorders as Potential Candidates for CD30-Targeted Therapies;Archives of Pathology & Laboratory Medicine;2022-03-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP